Significant RayStation Orders From Five UK Cancer Clinics

英国五个癌症中心对 RayStation 下新订单,总价值约为4800万瑞典克朗

2019-02-20 21:34:00 BioSpace

本文共1267个字,阅读需4分钟

Five cancer centers in the UK have placed new orders on the treatment planning system RayStation from RaySearch. The orders strengthen RaySearch's position in the UK market further. Christie Hospital, Manchester, significantly increases its current RayStation solution, approximately increasing their configuration 4-fold. The new order includes additional IMRT and VMAT capacity. Christie Hospital will use RayStation for the majority of its photon therapy treatments. Velindre Cancer Centre, Cardiff, also significantly increases its RayStation configuration and their order allows them to replace their existing solution and completely migrate all photon therapy treatments to RayStation. The three other clinics, Addenbrookes Hospital, Cambridge, Rosemere Cancer Centre, Preston, and James Cook University Hospital, Middlesbrough, are new customers. RayStation was chosen due to its superiority on the market, and for functionalities such as 3D-CRT, IMRT and VMAT capabilities, as well as advanced features like multi-criteria optimization and adaptive planning. The new orders put the number of RayStation clinics to 23 out of approximately 70 in the UK. This follows up the success from 2018, when over 80 % of all framework spending via NHS Supply Chain, on treatment planning systems, was for RayStation. Johan Löf, CEO of RaySearch, says: "I'm of course delighted that RayStation has been chosen by five prominent cancer centers in the UK. The UK market, with its combination of small facilities and large public institutions, focuses on advanced technology and the implementation of innovative solutions, which favors RayStation. We are really looking forward to an ongoing collaboration with all five centers." The total order value is about 48 million SEK, most of which will be recognized as revenue within Q1 2019. About RaySearch RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch's software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003. About RayCare RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow's requirements for advanced analytics and decision support in mind. About RayStation RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.
英国的五个癌症中心已经向 RaySearch 的治疗计划系统 RayStation 下了新的订单。这些订单进一步巩固了雷神搜索在英国市场的地位。 曼彻斯特的佳士得医院( ChristieHospital )大幅增加了目前的 RayStation 解决方案,大约增加了4倍的配置。新订单包括额外的 IMRT 和 VMAT 容量。佳士得医院将使用 RayStation 进行大部分光子治疗。 Cardiff 的 Velindre 癌症中心也显著增加了 RayStation 的配置,他们的顺序允许他们替换现有的解决方案,并将所有光子治疗转移到 RayStation 。 另外三家诊所,剑桥的 Addenbrookes 医院、普雷斯顿的 Rosemere 癌症中心和米德尔斯堡的 James Cook 大学医院都是新客户。选择 RayStation 是因为其在市场上的优势,以及3D-CRT 、 IMRT 和 VMAT 等功能,以及多标准优化和适应性规划等先进功能。 新的订单使得英国约70家雷站诊所中的23家。从2018年起,所有通过 NHS 供应链的框架支出中,超过80%用于治疗规划系统的 RayStation 就取得了成功。 RaySearch 首席执行官 Johan L ö f 说:“我当然很高兴 RayStation 被英国五个著名癌症中心选中。英国市场,其小型设施和大型公共机构的组合,侧重于先进的技术和实施创新的解决方案,这有利于雷站。我们非常期待与所有五个中心进行持续的合作。” 订单总价值约为4800万瑞典克朗,其中大部分将在2019年第一季度确认为收入。 关于雷射搜索 RaySearch 是一家开发创新软件解决方案以改善癌症护理的医疗技术公司。公司在全球范围内推广下一代肿瘤信息系统 RayStation 治疗规划系统和 RayCare *。超过2,600家诊所在超过65个国家使用雷神公司的软件改善患者的生活和结果。该公司成立于2000年,股份自2003年起在纳斯达克斯德哥尔摩上市。 关于 RayCare RayCare 旨在支持现代肿瘤诊所复杂的后勤挑战。它代表了肿瘤信息系统技术的未来,支持了一个肿瘤工作流的愿景。许多癌症患者接受治疗类型的组合, RayCare 旨在反映这一点。它将有效地协调放射治疗、化疗和手术活动,并为临床资源优化、工作流程自动化和适应性放射治疗提供先进的特点。RayCare 正在根据明天对高级分析和决策支持的要求进行开发。 关于雷达站 雷站是一个灵活的,创新的治疗规划系统,选择了许多世界领先的癌症中心。它结合了独特的特点,如无与伦比的自适应治疗能力,多准则优化,市场领先的算法 IMRT 和 VMAT 优化与高精度剂量发动机的光子,电子,质子和碳离子治疗。雷站支持广泛的治疗机器,提供一个控制中心的所有治疗规划需要,并确保中心获得更大的价值从现有设备。RayStation 还与下一代肿瘤信息系统 RayCare 无缝集成。通过协调治疗计划,我们可以更好地照顾全世界的癌症患者。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文